Publications

Publications:

  1. Gorjala, P., Kittles, R.A., O.B. Goodman, and Mitra, R*., Role of CYP3A5 in modulating androgen receptor signaling and its relevance to African American men with prostate cancer. Cancers (Basel), 2020. 12: p. 989. (*- communicating author)

  2. Hooker, S.E., Woods-Burnham, L., Bathina, M., Lloyd, S., Gorjala, P., Mitra, R., Nonn, L., Kimbro, K.S. and Kittles, R.A., Genetic ancestry analysis reveals misclassification of commonly used cancer cell lines. Cancer Epidemiology and prevention biomarkers, 2019. 28: p. 1003.

  3. Mitra, R*., T.T. Le, P. Gorjala and O.B. Goodman, Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5. BMC Cancer, 2017. 17: p. 1. (*- communicating author)

  4. Mitra, R. and O.B. Goodman, Jr., CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR. Prostate, 2015. 75(5): p. 527-38.

  5. Mitra, R., O.B. Goodman, and T.T. Le, Enhanced detection of metastatic prostate cancer cells in human plasma with lipid bodies staining. BMC Cancer, 2014. 14: p. 91.

  6. Mitra, R., et al., Negative regulation of NEP expression by hypoxia. Prostate, 2013. 73(7): p. 706-14.

  7. Mitra, R., et al., Detection of lipid-rich prostate circulating tumour cells with coherent anti-Stokes Raman scattering microscopy. BMC Cancer, 2012. 12: p. 540.

  8. Mitra, R., et al., CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (+/-)-14,15-epoxyeicosatrienoic acid (EET). J Biol Chem, 2011. 286(20): p. 17543-59.

  9. Mitra, R., et al., Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model. Clin Cancer Res, 2011. 17(9): p. 2934-46.

  10. Srirangam, A., Mitra, R., et al., The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin. J Thorac Oncol, 2011. 6(4): p. 661-70.

  11. Srirangam, A., Mitra, R*., et al., Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer. Clin Cancer Res, 2006. 12(6): p. 1883-96. (*- equal co- author)

  12. Mitra, R., H.K. Das, and A. Dixit, Identification of a positive transcription regulatory element within the coding region of the nifLA operon in Azotobacter vinelandii. Appl Environ Microbiol, 2005. 71(7): p. 3716-24.

Patents

Le TT, Mitra R, Urasaki Y, Goodman OB. Methods for therapeutic targeting of circulating tumor cells during hemodialysis. Patent Application No. 62/153,139 (2015).

Potter DA, Milani M, Srirangam A, Mitra R and Remmel RP. Treating cancer with desthiazolyl ritonavir published 08/06/2013 (patent number: 8501792) University of Minnesota.